MAHON PAUL A
Reporting owner on Forms 3, 4 and 5, CIK 1231589.
MAHON PAUL A reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-01.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| UNITED THERAPEUTICS Corp CIK 1082554 | officer (EVP & GENERAL COUNSEL) | 1 | 2026-10-01 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | M exercised | +8,300 | $146.03 | 53,472 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -880 | $558.3043 | 52,592 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -1,480 | $560.191 | 51,112 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -780 | $561.8705 | 50,332 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -1,480 | $563.0904 | 48,852 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -400 | $566.4062 | 48,452 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -720 | $567.7615 | 47,732 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -739 | $569.148 | 46,993 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -838 | $570.8964 | 46,155 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -823 | $572.2492 | 45,332 | Form 4 |
| UNITED THERAPEUTICS Corp Common Stock | 2026-10-01 | S sold | -160 | $573.15 | 45,172 | Form 4 |
| UNITED THERAPEUTICS Corp Stock Option, derivative | 2026-10-01 | M exercised | -8,300 | $0 | 39,240 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001231589-26-000021 | UNITED THERAPEUTICS Corp | 2026-10-01 |